BIOPHARMA SOLUTIONS

Valuable Insights – Cell by Cell, From Discovery to Launch
Our clinical solutions, proven by partnerships, help enhance drug development and expedite commercialization with valuable insights into the dynamics of cancer growth, evolution and heterogeneity. Comprehensive Cancer Profiling combines our proven and proprietary CTC capabilities, along with ctDNA and immune cell analysis to create a more complete picture for discovering new insights into the dynamics of cancer growth. We use our insights to develop clinical solutions that enhance drug development for proven clinical utility.

DECISION POINT menu

PROCESS

PHASE I/IB

  • Biomarker discovery
  • Novel PD marker development
  • Target and marker prevalence in larger cohorts
  • Efficacy analysis

PHASE II

  • Retrospective studies for marker efficacy
  • Prospective patient selection
  • Clinical analysis comparing marker efficacy vs. established endpoints
  • Identification of resistance signatures
  • CDx Development

PHASE III

  • LDT to PMA
  • Prospective analysis and CDx development
  • Regulatory support

AREAS OF FOCUS

breast

prostate

IMMUNO-ONCOLOGY (IO)

lung caNCER